Rocket Pharmaceuticals Inc buy melinda
Start price
03.01.17
/
50%
€6.22
Target price
29.03.17
€18.04
Performance (%)
11.59%
End price
29.03.17
€6.95
Summary
This prediction ended on 29.03.17 with a price of €6.95. The BUY prediction by melinda finished with a performance of 11.59%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Rocket Pharmaceuticals Inc | -0.523% | -0.523% | 35.591% | -41.601% |
| iShares Core DAX® | 1,93 % | -2,11 % | 11,14 % | 59,64 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % | -0,15 % | 82,45 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % | 28,83 % | 59,33 % |
| iShares S&P 500 | -0,20 % | -3,67 % | -0,10 % | 55,65 % |
Comments by melinda for this prediction
In the thread Rocket Pharmaceuticals Inc diskutieren
folgen
$ ITEK Herabstufung von Übergewicht bei Piper zu neutral. PT $ 3 $ 24
(Vom Mitglied beendet)
Stopped prediction by melinda for Rocket Pharmaceuticals Inc
Rocket Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€9.02
27.10.17
27.10.17
€18.04
29.12.17
29.12.17
8.40%
29.12.17
29.12.17
Rocket Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€10.00
27.10.17
27.10.17
€20.00
29.12.17
29.12.17
8.40%
29.12.17
29.12.17
Rocket Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€7.22
25.04.17
25.04.17
€7.58
26.04.17
26.04.17
5.00%
26.04.17
26.04.17